1108-109 Low hemoglobin is an independent predictor of adverse fatal and nonfatal outcomes in both reduced and preserved systolic function chronic heart failure: Findings from the candesartan in heart failure assessment of reduction in mortality and morbidity program (CHARM) Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • McMurray, John J
  • Lang, Chim C
  • Swedberg, Karl
  • Östergren, Jan
  • Granger, Christopher B
  • Michelson, Eric
  • Young, James B
  • Olofsson, Bertil
  • Dunlap, Mark
  • Yusuf, Salim
  • Pfeffer, Marc A

publication date

  • March 2004